Dr. Juncheng Wei 魏军成
Chief Physician, Associate Professor
Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of benign and malignant gynecologic conditions, including cervical, endometrial, ovarian, vaginal, and vulvar cancers, uterine sarcoma, gestational trophoblastic tumors, fibroids, ovarian cysts, and endometriosis.
Dr. Wei is a Chief Physician and Associate Professor with over ten years of clinical experience in obstetrics and gynecology. Dr. Wei performs complex open and minimally invasive laparoscopic surgeries, including radical hysterectomy for cervical cancer, endometrial cancer surgery, ovarian cancer staging, pelvic and abdominal lymph node dissection, myomectomy, hysterectomy, and ovarian cystectomy.
Name order: in Chinese the family name comes first (Wei Juncheng). Papers usually list the name as Juncheng Wei or Wei J.
Selected publications
42 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Hematol Oncol, 2025 (senior author): Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance. PubMed 40605007
- Int J Gynaecol Obstet, 2023 (senior author): Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial. PubMed 36939553
- Medicine (Baltimore), 2020 (senior author): Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery. PubMed 32569239
- Oncol Lett, 2018 (senior author): MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1. PubMed 29963147
- Clin Cancer Res, 2017 (first author): Tumor-associated Lymphatic Endothelial Cells Promote Lymphatic Metastasis By Highly Expressing and Secreting SEMA4C. PubMed 27401250
- Anticancer Res, 2008 (first author): Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. PubMed 18383865
- Ai Zheng, 2008 (first author): [Effects of vimentin on invasion and metastasis of prostate cancer cell lines PC-3M-1E8 and PC-3M-2B4]. PubMed 18184460
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion